GO:1901733 quercetin catabolic process: Flavonoid Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901733 quercetin catabolic process describes the chemical reactions and pathways that result in the breakdown of quercetin, a dietary flavonoid.
• Quercetin catabolism is part of the broader flavonoid degradation and polyphenol metabolism landscape, influencing the bioavailability and biological activity of quercetin.
• Enzymes such as cytochrome P450s, UDP-glucuronosyltransferases, sulfotransferases, and catechol-O-methyltransferases participate in quercetin biotransformation and catabolism.
• Quercetin catabolic products can retain or alter biological activities, including anti-inflammatory, antioxidant, and anticancer effects.
• Dysregulation of quercetin catabolism may impact diseases such as cancer, inflammatory conditions, and metabolic disorders.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable functional dissection of genes involved in quercetin catabolic process.
Description
Quercetin is a plant-derived flavonoid widely consumed in the human diet and extensively studied for its antioxidant, anti-inflammatory, and anticancer properties. The biological fate of quercetin depends not only on its absorption but also on its catabolic processing, which converts the parent compound into a variety of metabolites with distinct bioactivities. GO:1901733, quercetin catabolic process, provides a standardized ontology term to annotate the biochemical reactions and pathways that degrade quercetin. Understanding this process is essential for interpreting pharmacokinetic data, designing quercetin-based therapeutics, and predicting interactions with cellular metabolism. Research into quercetin catabolic process spans enzymology, cell biology, and clinical pharmacology. Studies have identified key enzymes and pathways that mediate quercetin breakdown, including phase I and phase II metabolic enzymes. The catabolic products can modulate signaling pathways such as AKT, ERK, and Nrf2, which are implicated in diseases ranging from cancer to neurodegeneration. Consequently, GO:1901733 serves as a focal point for researchers investigating flavonoid metabolism and its impact on human health. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of quercetin catabolic process. It covers the definition, biological importance, core mechanisms, key genes, regulatory aspects, disease associations, and experimental models, including CRISPR-based approaches. The goal is to support both human readers and generative AI systems in retrieving accurate, citable information about GO:1901733.
quercetin catabolic process At A Glance
| GO ID | GO:1901733 |
|---|---|
| GO term | quercetin catabolic process |
| Ontology | biological_process |
| Synonym | quercetin breakdown, quercetin catabolism, quercetin degradation |
| Major function | Breakdown of quercetin into metabolites |
| Related processes | Flavonoid metabolism, polyphenol catabolism, xenobiotic metabolism |
| Key enzymes | Cytochrome P450s, UDP-glucuronosyltransferases, sulfotransferases, catechol-O-methyltransferases |
| Biological context | Dietary flavonoid processing, cellular detoxification, metabolite signaling |
What Is GO:1901733?
GO:1901733 quercetin catabolic process is defined as the chemical reactions and pathways resulting in the breakdown of quercetin, a flavonoid polyphenol. This process encompasses enzymatic modifications that convert quercetin into smaller metabolites, which may include deglycosylation, oxidation, methylation, glucuronidation, sulfation, and ring fission. The term is a biological process in the Gene Ontology and is synonymous with quercetin breakdown, quercetin catabolism, and quercetin degradation.
Why Is quercetin catabolic process Important in Cell Biology?
Quercetin catabolic process is important because it determines the bioavailability, biological half-life, and metabolite profile of quercetin, a compound with documented anti-inflammatory, antioxidant, and anticancer activities. The catabolic products can exhibit altered or novel bioactivities, influencing cellular signaling pathways such as AKT, ERK, and Nrf2. Understanding this process aids in predicting drug interactions, optimizing therapeutic dosing, and elucidating mechanisms of quercetin in diseases including cancer, diabetes, and neuropathic pain.
• Determines the metabolic fate and bioavailability of dietary and supplemental quercetin.
• Generates metabolites with distinct biological activities that can modulate inflammation and immunity.
• Influences cancer-related signaling pathways, including AKT inhibition in polycystic ovary syndrome and endometrial cancer.
• Affects macrophage polarization and immune responses in respiratory viral infections.
• Modulates ferroptosis and oxidative stress via Nrf2/Slc7a11/Gpx4 pathways.
• Plays a role in decidualization and endometriosis through AKT-ERK-p53 signaling.
• Impacts skin health, including antioxidant effects, wound healing, and hyperpigmentation.
• Provides a target for CRISPR-based functional genomics to identify novel catabolic enzymes.
• Helps explain inter-individual variability in quercetin response and toxicity.
• Supports the development of quercetin derivatives with improved pharmacokinetic profiles.
What Happens During quercetin catabolic process?
Phase I Functionalization
In simple terms: The body first modifies quercetin to make it more reactive and easier to process.
Phase I catabolism of quercetin involves oxidation, reduction, and hydrolysis reactions primarily mediated by cytochrome P450 enzymes. These reactions introduce functional groups that prepare quercetin for subsequent conjugation or ring fission. For example, hydroxylation and demethylation can occur, altering the flavonoid backbone. This step is critical for initiating the breakdown of quercetin into smaller phenolic acids and other metabolites.
Phase II Conjugation
In simple terms: Quercetin or its phase I products are tagged with molecules like glucuronic acid or sulfate to make them more water-soluble.
Phase II conjugation reactions, including glucuronidation, sulfation, and methylation, are major pathways in quercetin catabolism. UDP-glucuronosyltransferases (UGTs), sulfotransferases (SULTs), and catechol-O-methyltransferases (COMTs) catalyze these reactions, producing conjugated metabolites that are often excreted or further degraded. These conjugates can retain biological activity and may serve as reservoirs for parent quercetin.
Ring Fission and Microbial Degradation
In simple terms: The flavonoid ring structure is broken down, often by gut bacteria, into smaller phenolic compounds.
The catabolic process can involve ring fission of the quercetin skeleton, leading to the formation of phenolic acids such as 3,4-dihydroxyphenylacetic acid and 3-(3-hydroxyphenyl)propionic acid. Gut microbiota play a significant role in this step, contributing to the overall catabolism of quercetin in vivo. These smaller metabolites can be absorbed and exert systemic effects.
Regulation by Cellular Signaling
In simple terms: Cellular signals can speed up or slow down the breakdown of quercetin.
Quercetin catabolism is influenced by cellular signaling pathways such as AKT, ERK, and Nrf2. For instance, quercetin-induced AKT inhibition can affect downstream metabolic enzymes, while Nrf2 activation modulates oxidative stress responses that intersect with quercetin metabolism. These regulatory mechanisms ensure that quercetin catabolism is integrated with cellular stress and survival pathways.
Metabolite Excretion and Recycling
In simple terms: The breakdown products are either removed from the body or reused.
Catabolic metabolites of quercetin are subject to excretion via urine or bile, or they can be recycled through enterohepatic circulation. The balance between excretion and recycling affects the overall bioavailability and duration of action of quercetin. Understanding these dynamics is essential for therapeutic applications.
Key Genes Involved in GO:1901733 quercetin catabolic process
The following genes and proteins have been implicated in quercetin catabolic process or its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP1A1 | Phase I oxidation of flavonoids | Potential target for modulating quercetin catabolism |
| CYP1B1 | Phase I oxidation | Involved in quercetin metabolite formation |
| UGT1A1 | Glucuronidation of quercetin | Affects quercetin bioavailability |
| UGT1A9 | Glucuronidation | Major enzyme in quercetin phase II metabolism |
| SULT1A1 | Sulfation of quercetin | Modulates quercetin metabolite profile |
| COMT | Methylation of quercetin | Produces methylated quercetin metabolites |
| AKT1 | Signaling kinase | Quercetin inhibits AKT; linked to catabolic regulation |
| ERK2 | Signaling kinase | Involved in quercetin-induced decidualization |
| TP53 | Tumor suppressor | Quercetin affects p53 signaling in endometriosis |
| NFE2L2 | Transcription factor Nrf2 | Regulates antioxidant response and quercetin effects |
| SLC7A11 | Cystine/glutamate transporter | Modulated by quercetin in ferroptosis |
| GPX4 | Glutathione peroxidase | Involved in quercetin-mediated ferroptosis inhibition |
| IL6 | Inflammatory cytokine | Quercetin modulates inflammation |
| TNF | Inflammatory cytokine | Quercetin affects TNF signaling |
| NLRP3 | Inflammasome component | Quercetin may influence inflammasome activity |
| MIR21 | MicroRNA | Potential regulator of quercetin metabolism |
| BCL2 | Apoptosis regulator | Quercetin affects apoptosis in cancer cells |
| BAX | Apoptosis regulator | Modulated by quercetin |
How Is quercetin catabolic process Regulated?
Quercetin catabolic process is regulated at multiple levels, including enzyme expression, post-translational modifications, and cellular signaling pathways. The AKT signaling pathway has been shown to be inhibited by quercetin, which may feedback on catabolic enzyme activity. The Nrf2 pathway regulates antioxidant responses and can influence quercetin metabolism and its effects on ferroptosis. Additionally, ERK and p53 signaling are involved in quercetin-induced cellular responses that may intersect with catabolic pathways. Inflammatory mediators such as IL-6 and TNF can also modulate quercetin metabolism in immune cells. Overall, quercetin catabolism is dynamically regulated to maintain cellular homeostasis.
quercetin catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AKT1 | Endometrial cancer, PCOS | Knockout in cancer cell lines |
| NFE2L2 | Diabetic kidney disease, neuropathic pain | Knockout in rodent models |
| SLC7A11 | Ferroptosis, spinal cord injury | Overexpression in microglial cells |
| GPX4 | Ferroptosis | Point mutation in neuronal cells |
| IL6 | Inflammation, RSV infection | Knockout in macrophages |
Quercetin Catabolism in Cancer
Quercetin and its catabolic metabolites have been studied in various cancers, including endometrial cancer and polycystic ovary syndrome (PCOS)-associated cancer. Network pharmacology studies suggest that quercetin's inhibition of AKT in co-expressed genes may affect cancer cell proliferation and survival. The catabolic process can generate metabolites that retain anticancer activity or modulate drug resistance. Understanding quercetin catabolism is therefore relevant for developing flavonoid-based cancer therapies.
Quercetin Catabolism in Inflammatory and Immune Diseases
Quercetin catabolism influences inflammation and immunity, as quercetin and its metabolites can modulate macrophage polarization and cytokine production. In respiratory syncytial virus (RSV) infection, quercetin induces itaconic acid-mediated M1/M2 alveolar macrophage polarization, which is linked to its catabolic processing. These effects highlight the role of quercetin catabolism in infectious and inflammatory diseases.
Quercetin Catabolism in Metabolic and Neurological Disorders
Quercetin catabolism is implicated in diabetic kidney disease, where quercetin inhibits ferroptosis and regulates Nrf2. In neuropathic pain and spinal cord injury, quercetin-loaded hydrogels inhibit microglial ferroptosis through the Nrf2/Slc7a11/Gpx4 pathway, suggesting a role for quercetin metabolites in neuroprotection. These findings underscore the therapeutic potential of targeting quercetin catabolism in metabolic and neurological conditions.
Quercetin Catabolism in Skin Health
A systematic review and meta-analysis on quercetin for skin problems indicates antioxidant effects, wound healing, and anti-aging properties, which may be influenced by quercetin catabolism. The metabolites generated during catabolism can affect oxidative stress and inflammation in skin cells. Thus, quercetin catabolic process is relevant to dermatological research and skincare applications.
From quercetin catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate quercetin catabolism? | CRISPR knockout in HepG2 cells |
| Does a specific point mutation alter enzyme activity? | CRISPR point mutation in UGT1A1 |
| Can a tagged enzyme be used to track quercetin metabolites? | Knock-in of FLAG-tag in COMT |
| Does overexpression of a catabolic enzyme enhance quercetin breakdown? | Overexpression in HEK293T cells |
| What is the role of AKT in quercetin catabolism? | AKT1 knockout in cancer cells |
| How does Nrf2 affect quercetin metabolism? | Nrf2 knockout in diabetic kidney models |
How to Study the quercetin catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Quercetin and metabolite levels | Profiling catabolic pathways |
| CRISPR knockout screen | Gene essentiality for catabolism | Identifying novel catabolic genes |
| RNA-seq | Gene expression changes | Transcriptomic response to quercetin |
| Proteomics | Protein abundance | Quantifying catabolic enzymes |
| Enzyme activity assay | Catalytic activity | Validating enzyme function |
| Western blot | Protein expression | Confirming knockout/overexpression |
| Immunofluorescence | Subcellular localization | Tracking tagged enzymes |
| Flow cytometry | Cell phenotype | Macrophage polarization |
Metabolomics and Mass Spectrometry
Liquid chromatography-mass spectrometry (LC-MS) is the gold standard for profiling quercetin and its catabolic metabolites in biological samples. This method allows quantification of phase I and phase II metabolites, providing insights into catabolic pathways. Targeted metabolomics can identify specific enzymes involved in quercetin breakdown.
CRISPR Screening for Catabolic Genes
Genome-wide CRISPR knockout screens can identify genes essential for quercetin catabolism. By treating cells with quercetin and measuring viability or metabolite levels, researchers can pinpoint catabolic enzymes and regulators. This approach is powerful for discovering novel players in the pathway.
RNA Sequencing and Transcriptomics
RNA-seq can reveal changes in gene expression upon quercetin treatment, highlighting catabolic enzymes and signaling pathways. Transcriptomic profiling of cells with CRISPR-mediated knockouts can further elucidate regulatory networks.
Proteomics and Enzyme Activity Assays
Proteomic analysis can quantify catabolic enzyme abundance, while activity assays measure their catalytic efficiency. These methods are useful for validating CRISPR models and understanding post-translational regulation.
How CRISPR Can Be Used to Study GO:1901733 quercetin catabolic process
Knockout
CRISPR knockout of candidate genes such as UGT1A1 or COMT can abolish specific quercetin catabolic steps, leading to accumulation of parent quercetin or upstream metabolites. These models are essential for assigning enzyme function in the pathway.
Point Mutation
Introducing point mutations in catalytic residues of catabolic enzymes can dissect their mechanism and assess the impact on quercetin metabolism. For example, mutating the active site of a sulfotransferase can reveal substrate specificity.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) into endogenous catabolic genes allows tracking of enzyme localization and interaction with quercetin metabolites. This approach preserves native regulation.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can boost catabolic enzyme levels, enhancing quercetin breakdown and enabling studies of metabolite effects. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports quercetin catabolic process Research
Researchers studying quercetin catabolic process-related genes often need to determine whether a candidate gene is causally involved in the breakdown of quercetin or its biological effects. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes implicated in GO:1901733.
Contact EDITGENE today to design your custom CRISPR model for quercetin catabolic process research.
Frequently Asked Questions About quercetin catabolic process
What is quercetin catabolic process?
Quercetin catabolic process (GO:1901733) is the set of biochemical reactions that break down quercetin into smaller metabolites.
What genes are involved in quercetin catabolic process?
Genes encoding cytochrome P450s, UGTs, SULTs, and COMT are involved in quercetin catabolism.
How is quercetin catabolized in the body?
Quercetin undergoes phase I oxidation and phase II conjugation, followed by ring fission and excretion.
What are the metabolites of quercetin catabolism?
Metabolites include glucuronidated, sulfated, and methylated quercetin, as well as phenolic acids.
Why is quercetin catabolism important for health?
It determines quercetin bioavailability and the bioactivity of its metabolites, affecting inflammation, cancer, and metabolic diseases.
Can CRISPR be used to study quercetin catabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can dissect gene function in quercetin catabolism.
What diseases are linked to quercetin catabolism?
Cancer, inflammatory diseases, diabetic kidney disease, neuropathic pain, and skin disorders.
How does quercetin affect AKT signaling?
Quercetin inhibits AKT, which may influence catabolic pathways and disease outcomes.
What is the role of Nrf2 in quercetin catabolism?
Nrf2 regulates antioxidant responses that intersect with quercetin metabolism and ferroptosis.
How can I model quercetin catabolism in the lab?
Use CRISPR-engineered cell lines and metabolomic profiling to study specific genes and pathways.
Conclusion
GO:1901733 quercetin catabolic process is a vital biological process that governs the fate and bioactivity of quercetin, a dietary flavonoid with broad therapeutic potential. Understanding its mechanisms, key genes, and regulation is essential for interpreting quercetin's effects in health and disease. CRISPR-based models provide powerful tools to dissect this pathway and identify novel targets for intervention. EDITGENE's services support researchers in generating precise cell models to advance quercetin catabolism research.
References
- 1. Li Y et al.. 2016. Quercetin, Inflammation and Immunity.. Nutrients 8(3):167 PMID: 26999194
- 2. Alizadeh SR et al.. 2022. Quercetin derivatives: Drug design, development, and biological activities, a review.. Eur J Med Chem 229:114068 PMID: 34971873
- 3. Li M et al.. 2025. Integrating network pharmacology to investigate the mechanism of quercetin's action through AKT inhibition in co-expressed genes associated with polycystic ovary syndrome and endometrial cancer.. Int J Biol Macromol 297:139468 PMID: 39765297
- 4. An L et al.. 2024. Quercetin induces itaconic acid-mediated M1/M2 alveolar macrophages polarization in respiratory syncytial virus infection.. Phytomedicine 130:155761 PMID: 38797031
- 5. Li L et al.. 2025. Injectable ROS homeostasis protective hydrogel inhibiting microglial ferroptosis through the Nrf2/Slc7a11/Gpx4 to alleviate neuropathic pain and promote spinal cord injury repair.. Redox Biol 86:103816 PMID: 40795617
- 6. Delenko J et al.. 2024. Quercetin enhances decidualization through AKT-ERK-p53 signaling and supports a role for senescence in endometriosis.. Reprod Biol Endocrinol 22(1):100 PMID: 39118090
- 7. Zhang L et al.. 2024. Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats.. Ren Fail 46(1):2327495 PMID: 38465879
- 8. Okselni T et al.. 2025. Quercetin as a therapeutic agent for skin problems: a systematic review and meta-analysis on antioxidant effects, oxidative stress, inflammation, wound healing, hyperpigmentation, aging, and skin cancer.. Naunyn Schmiedebergs Arch Pharmacol 398(5):5011-5055 PMID: 39738831
